Ramesh Rajagopal
Chief Executive Officer at Authentic8, Inc.
Profile
Ramesh Rajagopal is the founder of Authentic8, Inc. (founded in 2010) where he currently holds the title of Chief Executive Officer.
He previously worked as a Senior Director in the Corporate Strategy Group at Microsoft Corp.
and as a Director at Horizon Pharma, Inc. and Agosto, Inc. He also served as Vice President of Corporate Development at Postini, Inc. Mr. Rajagopal received his undergraduate degree from the University of Cambridge and his MBA from the University of Chicago.
Ramesh Rajagopal active positions
| Companies | Position | Start |
|---|---|---|
Authentic8, Inc.
 Authentic8, Inc. Packaged SoftwareTechnology Services Authentic8, Inc. provides Internet browser technologies and cloud services. It offers Silo which helps to manage login credentials, device access controls data use policies, secure storage and attribution. The company was founded by Scott Petry and Ramesh Rajagopal in 2010 and is headquartered in Mountain View, CA. | Chief Executive Officer | 2009-12-31 |
Former positions of Ramesh Rajagopal
| Companies | Position | End |
|---|---|---|
| MICROSOFT CORPORATION | Corporate Officer/Principal | - |
Postini, Inc.
 Postini, Inc. Packaged SoftwareTechnology Services Postini, Inc. offered on-demand communications security, compliance and productivity solutions for email, instant messaging, and Web applications. It use to delivers message filtering, encryption, security, and archiving solutions for business environments. The company was incorporated in December 13, 1999 and was headquartered in Mountainview, CA. | Corporate Officer/Principal | - |
Agosto, Inc.
 Agosto, Inc. Information Technology ServicesTechnology Services Agosto, Inc. engages in the provision of custom cloud product development. It offers Skykit Digital Signage, G Suite Business, G Suite Basic, Google Chrome, Google Maps, and Google Enterprise Search. The firm also offers cloud solutions, enterprise digital signage platform, IOT product development, cloud product development, Google cloud platform, G suite Migration and deployment, and change management and training for G suite. The company was founded by Irfan Khan and Rick Erickson in 2001 and is headquartered in Minneapolis, MN. | Director/Board Member | - |
Horizon Pharma, Inc.
 Horizon Pharma, Inc. Pharmaceuticals: MajorHealth Technology Horizon Pharma, Inc. discovers and develops medicines for the treatment of chronic inflammatory diseases. It is a specialty pharmaceutical company that has developed and is commercializing DUEXIS and RAYOS, both of which target unmet therapeutic needs in arthritis, pain and inflammatory diseases. The company products include DUEXIS (ibuprofen and famotidine) Tablets, is a proprietary, single-tablet combination of the non-steroidal anti-inflammatory drug ibuprofen and the histamine H2-receptor antagonist famotidine; RAYOS (prednisone) delayed-release tablets, known as LODOTRA outside the U.S., is a proprietary delayed-release formulation of low-dose prednisone for the treatment of moderate to severe, active RA in adults, particularly when accompanied by morning stiffness. Horizon Pharma was founded on March 23, 2010 and is headquartered in Deerfield, IL. | Director/Board Member | - |
Training of Ramesh Rajagopal
| The University of Chicago | Masters Business Admin |
| University of Cambridge | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| MICROSOFT CORPORATION | Technology Services |
| Private companies | 4 |
|---|---|
Horizon Pharma, Inc.
Horizon Pharma, Inc. Pharmaceuticals: MajorHealth Technology Horizon Pharma, Inc. discovers and develops medicines for the treatment of chronic inflammatory diseases. It is a specialty pharmaceutical company that has developed and is commercializing DUEXIS and RAYOS, both of which target unmet therapeutic needs in arthritis, pain and inflammatory diseases. The company products include DUEXIS (ibuprofen and famotidine) Tablets, is a proprietary, single-tablet combination of the non-steroidal anti-inflammatory drug ibuprofen and the histamine H2-receptor antagonist famotidine; RAYOS (prednisone) delayed-release tablets, known as LODOTRA outside the U.S., is a proprietary delayed-release formulation of low-dose prednisone for the treatment of moderate to severe, active RA in adults, particularly when accompanied by morning stiffness. Horizon Pharma was founded on March 23, 2010 and is headquartered in Deerfield, IL. | Health Technology |
Postini, Inc.
Postini, Inc. Packaged SoftwareTechnology Services Postini, Inc. offered on-demand communications security, compliance and productivity solutions for email, instant messaging, and Web applications. It use to delivers message filtering, encryption, security, and archiving solutions for business environments. The company was incorporated in December 13, 1999 and was headquartered in Mountainview, CA. | Technology Services |
Agosto, Inc.
Agosto, Inc. Information Technology ServicesTechnology Services Agosto, Inc. engages in the provision of custom cloud product development. It offers Skykit Digital Signage, G Suite Business, G Suite Basic, Google Chrome, Google Maps, and Google Enterprise Search. The firm also offers cloud solutions, enterprise digital signage platform, IOT product development, cloud product development, Google cloud platform, G suite Migration and deployment, and change management and training for G suite. The company was founded by Irfan Khan and Rick Erickson in 2001 and is headquartered in Minneapolis, MN. | Technology Services |
Authentic8, Inc.
Authentic8, Inc. Packaged SoftwareTechnology Services Authentic8, Inc. provides Internet browser technologies and cloud services. It offers Silo which helps to manage login credentials, device access controls data use policies, secure storage and attribution. The company was founded by Scott Petry and Ramesh Rajagopal in 2010 and is headquartered in Mountain View, CA. | Technology Services |
- Stock Market
- Insiders
- Ramesh Rajagopal
